Add to ORKGTamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use. Copyright © 2006 by Razi Institute for Drug Research (RIDR)
Recent studies have indicated that the tamoxifen-related risk of uterine cor-pus cancer may be espec...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Tamoxifen, an anti-estrogen agent that can suppress breast cancer, has been reported to increase end...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Journal URL: http://www.spandidos-publications.com/or/The use of tamoxifen for breast cancer therapy...
Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
Case: A 67-year-old multiparous woman received 20 mg tamoxifen daily for four years after surgical t...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
INTRODUCTION: Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive...
Abstract Objective: Selective estrogen receptor modulators (SERMs) such as tamoxifen play a role in ...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
Recent studies have indicated that the tamoxifen-related risk of uterine cor-pus cancer may be espec...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Tamoxifen, an anti-estrogen agent that can suppress breast cancer, has been reported to increase end...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Journal URL: http://www.spandidos-publications.com/or/The use of tamoxifen for breast cancer therapy...
Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
Case: A 67-year-old multiparous woman received 20 mg tamoxifen daily for four years after surgical t...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
INTRODUCTION: Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive...
Abstract Objective: Selective estrogen receptor modulators (SERMs) such as tamoxifen play a role in ...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
Recent studies have indicated that the tamoxifen-related risk of uterine cor-pus cancer may be espec...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Tamoxifen, an anti-estrogen agent that can suppress breast cancer, has been reported to increase end...